TLC BioSciences Company Description

TLC BioSciences Corp. operates as a clinical-stage biotechnology company that develops and sells lipid-engineered medicines in Taiwan, the United States of America, Europe, and the Cayman Islands.

It offers products based on its proprietary LipAD, a drug delivery platforms, including BioSeizer for sustained release; NanoX for targeted delivery; and Genosphere for regenerative medicine.

The company's pipeline includes candidates for orthopedics and pain management, metabolic and immune disorders, and infectious diseases.

The company was founded in 1997 is based in Taipei, Taiwan.

TLC BioSciences Corp.

Country	Cayman Islands
Founded	1997
Industry	Biological Products, Except Diagnostic Substances
CEO	Zhi-Hong Yeh

Contact Details

Address: 3 Park Street Taipei, 11503 Taiwan
Phone	886 2 2655 7377
Website	tlcbio.com

Stock Details

Ticker Symbol	7924
Exchange	Taipei Exchange
Reporting Currency	TWD
SIC Code	2836

Key Executives

Name	Position
Zhi-Hong Yeh	Chief Executive Officer